High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO)

Tero Ylisaukko-oja, Jaakko Aaltonen, Heikki Nuutinen, Timo Blomster, Airi Jussila, Markku Pajala, Kimmo Salminen, Veikko Moilanen, Kalle Hakala, Mikko Kellokumpu, Kari Toljamo, Henna Rautiainen, Juha Kuisma, Markku Peräaho, Pauliina Molander, Jouni Silvennoinen, Ville Liukkonen, Hans Henricson, Jyrki Tillonen, Mirva EsterinenChristian Nielsen, Eija Hirsi, Margus Lääne, Ulla-Maija Suhonen, Ilkka Vihriälä, Petri Mäkelä, Mika Puhto, Jari Punkkinen, Hannu Sulonen, Sauli Herrala, Jari Jokelainen, Klaus Tamminen, Taina Sipponen

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalScandinavian Journal of Gastroenterology
Volume53
Issue number2
Pages (from-to)158-167
Number of pages10
ISSN0036-5521
DOIs
Publication statusPublished - 2018
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Biological therapy
  • Crohn's disease
  • endoscopy
  • real-world effectiveness
  • ulcerative colitis
  • vedolizumab
  • EFFICACY END-POINTS
  • CROHNS-DISEASE
  • MAINTENANCE THERAPY
  • ULCERATIVE-COLITIS
  • FECAL CALPROTECTIN
  • INDUCTION THERAPY
  • ACTIVITY INDEXES
  • MEDICAL THERAPY
  • CLINICAL-TRIALS
  • REMISSION
  • 3121 Internal medicine

Cite this